Comparative activity of carbapenem testing (the COMPACT study) in Turkey

BMC Infectious Diseases

Volumn 12, Issue , 2012, Pages

  Leblebicioglu, Hakan ^a   Cakir, Nedim ^b   Celen, Mustafa ^c   Kurt, Halil ^d   Baris, Hakan ^e   Laeuffer, Joerg ^f  

^a ONDOKUZ MAYIS UNIVERSITY   (Turkey)

^b DOKUZ EYLUL UNIVERSITY   (Turkey)

^c DICLE UNIVERSITY   (Turkey)

^d ANKARA UNIVERSITY   (Turkey)

^e Janssen Turkey   (Turkey)

^f Janssen EMEA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM; DORIPENEM; IMIPENEM; MEROPENEM; ANTIINFECTIVE AGENT; CARBAPENEM DERIVATIVE;

ABDOMINAL INFECTION; ARTICLE; BACTERIUM ISOLATE; BLOODSTREAM INFECTION; CONTROLLED STUDY; DRUG ACTIVITY; ENTEROBACTERIACEAE; GRAM NEGATIVE BACTERIUM; HOSPITAL INFECTION; INTENSIVE CARE UNIT; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA; QUALITY CONTROL; TURKEY (REPUBLIC); VENTILATOR ASSOCIATED PNEUMONIA; ACINETOBACTER BAUMANNII; ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; CHILD; COMPARATIVE STUDY; CROSS INFECTION; DRUG EFFECT; FEMALE; GRAM NEGATIVE INFECTION; HOSPITAL; HUMAN; INFANT; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD;

ACINETOBACTER BAUMANNII; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; CARBAPENEMS; CHILD; CHILD, PRESCHOOL; CROSS INFECTION; ENTEROBACTERIACEAE; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HOSPITALS; HUMANS; INFANT; INFANT, NEWBORN; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PSEUDOMONAS AERUGINOSA; TURKEY; YOUNG ADULT;

EID: 84856929992     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-12-42     Document Type: Article

References (16)

1. Health Protection Agency: Surveillance of healthcare associated infections report. , http://www.hpa.org.uk/web/HPAwebFile/HPAweb_C/1216193833496
2. Turner PJ. MYSTIC Europe 2007: activity of meropenem and other broad-spectrum agents against nosocomial isolates. Diagn Microbiol Infect Dis 2009, 63:217-222. 10.1016/j.diagmicrobio.2008.11.004, 19070453.
3. Gur D, Korten V, Unal S, Deshpande LM, Castanheira M. Increasing carbapenem resistance due to the clonal dissemination of oxacillinase (OXA-23 and OXA-58)-producing Acinetobacter baumannii: report from the Turkish SENTRY Program sites. J Med Microbiol 2008, 57:1529-1532. 10.1099/jmm.0.2008/002469-0, 19018025.
4. Jones RN, Huynh HK, Biedenbach DJ, Fritsche TR, Sader HS. Doripenem (S-4661), a novel carbapenem: comparative activity against contemporary pathogens including bactericidal action and preliminary in vitro methods evaluations. J Antimicrob Chemother 2004, 54:144-154. 10.1093/jac/dkh298, 15190031.
5. Doribax Annex I. Summary of product characteristics. European Medicines Agency Doribax., http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000891/WC500037148.pdf
6. Doribax [package insert]. 2009, Ortho-McNeil: Raritan, NJ.
7. Clinical and Laboratory Standards Institute Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically 2009, Wayne, PA, 8, Clinical and Laboratory Standards Institute.
8. Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing; Twentieth Informational Supplement (June 2010 Update) 2010, Wayne, PA, Clinical and Laboratory Standards Institute.
9. Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing 2009, Wayne, PA, 19, Clinical and Laboratory Standards Institute.
10. European Committee on Antimicrobial Susceptibility Testing Breakpoint tables for interpretation of MICs and zone diameters. Version 1.2. European Committee on Antimicrobial Susceptibility Testing., http://www.eucast.org/
11. Nordmann P, Picazo JJ, Mutters R, Korten V, Quintana A, Laeuffer JM, Seak JC, Flamm RK, Morrissey I, . The COMPACT study group The Comparative Activity of Carbapenem Testing (COMPACT) study. J Antimicrob Chemother 2011, 66:1070-1078. 10.1093/jac/dkr056, 21393160, The COMPACT study group.
12. Erdem I, Ozgultekin A, Inan AS, Dincer E, Turan G, Ceran N, Engin DO, Akcay SS, Akgun N, Goktas P. Incidence, etiology, and antibiotic resistance patterns of Gram-negative microorganisms isolated from patients with ventilator-associated pneumonia in a medical-surgical intensive care unit of a teaching hospital in Istanbul, Turkey (2004-2006). Jpn J Infect Dis 2008, 61:339-342.
13. Kucukates E. Antimicrobial resistance among Gram-negative bacteria isolated from intensive care units in a cardiology institute in Istanbul, Turkey. Jpn J Infect Dis 2005, 58:228-231.
14. Livermore DM, Hope R, Brick G, Lillie M, Reynolds R, . The BSAC Working Parties on Resistance Surveillance Non-susceptibility trends among Enterobacteriaceae from bacteraemias in the UK and Ireland, 2001-06. J Antimicrob Chemother 2008, 62(suppl 2):ii41-ii54. The BSAC Working Parties on Resistance Surveillance.
15. Korten V, Ulusoy S, Zarakolu P, Mete B, . Turkish MYSTIC Study Group Antibiotic resistance surveillance over a 4-year period (2000-2003) in Turkey: results of the MYSTIC Program. Diagn Microbiol Infect Dis 2007, 59:453-457. 10.1016/j.diagmicrobio.2007.06.016, 17888609, Turkish MYSTIC Study Group.
16. Christiansen KJ, Ip M, Ker HB, Mendoza M, Hsu L, Kiratisin P, Chongthaleong A, Redjeki IS, Quintana A, Flamm R, Garcia J, Cassettari M, Cooper D, Okolo P, Morrissey I. In vitro activity of doripenem and other carbapenems against contemporary Gram-negative pathogens isolated from hospitalised patients in the Asia-Pacific region: results of the COMPACT Asia-Pacific Study. Int J Antimicrob Agents 2010, 36:501-506. 10.1016/j.ijantimicag.2010.08.002, 20869212.